UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Review article: pharmacotherapy for alcohol dependence - the why, the what and the wherefore

Goh, ET; Morgan, MY; (2017) Review article: pharmacotherapy for alcohol dependence - the why, the what and the wherefore. Alimentary Pharmacology & Therapeutics , 45 (7) pp. 865-882. 10.1111/apt.13965. Green open access

[thumbnail of Morgan_MYM accepted for deposit Pharmacotherapy for Alcohol Dependence Jan 2017 for APT.pdf]
Preview
Text
Morgan_MYM accepted for deposit Pharmacotherapy for Alcohol Dependence Jan 2017 for APT.pdf - Accepted Version

Download (701kB) | Preview

Abstract

BACKGROUND: The development of alcohol dependence is associated with significant morbidity and mortality. For the majority of affected people the most appropriate goal, in terms of drinking behaviour, is abstinence from alcohol. Psychosocial intervention is the mainstay of the treatment but adjuvant pharmacotherapy is also available and its use recommended. AIM: To provide an updated analysis of current and potential pharmacotherapeutic options for the management of alcohol dependence. In addition, factors predictive of therapeutic outcome, including compliance and pharmacogenetics, and the current barriers to treatment, including doctors' unwillingness to prescribe these agents, will be explored. METHODS: Relevant papers were selected for review following extensive, language- and date-unrestricted, electronic and manual searches of the literature. RESULTS: Acamprosate and naltrexone have a substantial evidence base for overall efficacy, safety and cost-effectiveness while the risks associated with the use of disulfiram are well-known and can be minimised with appropriate patient selection and supervision. Acamprosate can be used safely in patients with liver disease and in those with comorbid mental health issues and co-occurring drug-related problems. A number of other agents are being investigated for potential use for this indication including: baclofen, topiramate and metadoxine. CONCLUSION: Pharmacotherapy for alcohol dependence has been shown to be moderately efficacious with few safety concerns, but it is substantially underutilised. Concerted efforts must be made to remove the barriers to treatment in order to optimise the management of people with this condition.

Type: Article
Title: Review article: pharmacotherapy for alcohol dependence - the why, the what and the wherefore
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1111/apt.13965
Publisher version: http://dx.doi.org/10.1111/apt.13965
Language: English
Additional information: This is the peer reviewed version of the following article: Goh, ET; Morgan, MY; (2017) Review article: pharmacotherapy for alcohol dependence - the why, the what and the wherefore. Alimentary Pharmacology & Therapeutics 10.1111/apt.13965. (In press), which has been published in final form at 10.1111/apt.13965. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inst for Liver and Digestive Hlth
URI: https://discovery.ucl.ac.uk/id/eprint/1542523
Downloads since deposit
325Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item